• Welcome to the online home of the Oman Medical Journal offering free access and publishing to all authors and researchers 

    Welcome from the Editor-in-Chief

    Prof. Ibrahim Al-Zakwani BSc, MSc, MS, PhD

    Welcome to the home of the Oman Medical Journal. The OMJ was established in 1984 and has been published under the Oman Medical Specialty Board since 2007. Initially, we started with one issue a year, which later increased to four and then to six in 2011. We currently publish over 100 articles a year covering all aspects of medicine and healthcare. These are selected by our committed and multi-disciplinary Editorial Board.

    We take a no barriers approach to publishing and are proud to offer the journal free to all those who wish to read it and charge no publication fees to authors/researchers. We publish a wide range of articles, including original research, case reports, and preliminary studies. We also publish editorials and letters intended to inform and spark debate about key medical issues. We do this to complement OMSB’s mission to provide quality healthcare through quality medical education. As part of this commitment, we are listed and indexed in over 35 databases, and this number continues to grow.

    We have added some exciting new features to this website. We now offer our authors the opportunity to publish their articles as soon as they are accepted with our preprint facility.  

    On behalf of the entire OMJ team, thank you for visiting the online home of the OMJ. We hope you will find this site to be a helpful resource. Please do not hesitate to contact us with any questions, concerns, or comments you have.

    Ibrahim Al-Zakwani

    Articles and Issues


    Most Viewed Articles

    The most viewed articles from the OMJ.
    Volume 37, Issue 1 January 2022
    Anaphylaxis in Omani Patients: A Study from a Tertiary Care Center

    Salem Al Tamemi, Yusra Al Lamki, Shafiq Ur-Rehman Naseem, Nabila Al Siyabi, Bushra Al Siyabi, Ibrahim Al-Zakwani

    Objectives: Anaphylaxis is an acute and potentially fatal allergic reaction. No studies have yet been conducted to evaluate the spectrum of anaphylactic reactions among Omani patients. As such, this study aimed to describe the clinical features, causes, investigation, and management of anaphylaxis among patients presenting to a tertiary care center in Oman. Methods: This retrospective study took place between August 2005 and June 2020 at the allergy and immunology clinic of Sultan Qaboos University Hospital, Muscat, Oman. All patients diagnosed with anaphylaxis during the study period were included. Data were collected from electronic medical records. Results: One hundred patients were diagnosed with anaphylaxis during the study period. Of these, 52.0% were male. The mean age was 15.9±16.2 years, with 70.0% aged < 18 years old. The eosinophil count ranged from 0.0–16.9 × 109/L, with a mean of 0.8±2.2 × 109/L and a median of 0.3 (0.1–0.6) × 109/L. Total immunoglobulin (Ig) E levels ranged from 25–8706 kIU/L, with a mean of 935.1±1369.5 kIU/L and a median of 500.4 (186.0–972.5) kIU/L. The majority of patients had a family history of allergies (72.0%), and other had concomitant allergic conditions (66.0%). All were prescribed epinephrine (100%). The most common cause of anaphylaxis was food (65.0%). The second most frequent trigger was insect venom (32.0%). Most patients had one category cause (81.0%); two or more causes were present in 12.0% of patients. Clinical symptoms manifested most frequently as cutaneous (92.0%) and respiratory (85.0%). The majority of patients (87.0%) demonstrated the involvement of more than one bodily system. Mean total IgE levels were significantly higher in patients with concomitant presence of other allergic conditions (1193.8 kIU/L) than patients without another concomitant allergic disease (503.6 kIU/L; p = 0.030). In addition, concomitant allergic disease is significantly higher in patients < 18 years of age (75.4%) compared to patients > 18 years of age (45.2%; p = 0.010). Conclusions: Due to its life-threatening nature, knowledge of the epidemiology and clinical features of anaphylaxis in different populations is necessary to deliver rapid treatment. This study found that the clinical features of anaphylactic patients in Oman were similar to those reported elsewhere. Further research is needed to determine the true incidence of anaphylaxis in Oman to minimize associated morbidity and mortality.

    Article history:

    Volume 37, Issue 1 January 2022
    Oman Medical Specialty Board Research Forum 2021/2022: Abstracts


    Article history:

    For Authors

    The Oman Medical Journal accepts manuscript submissions through an external website, Editorial Manager.  

    The Journal has specific instructions and guidelines for submitting articles. Please read and review them carefully. Articles that are not submitted in accordance with our instructions and guidelines are more likely to be rejected.

    About OMJ

    "Oman Medical Journal is an Open Access International Journal, which intends to engage and inform doctors, researchers and other health professionals by publishing a wide range of peer-reviewed articles."

    Contact Us

    "Our background is solidly grounded in publishing a high degree of articles covering all aspects of medicine."
      Oman Medical Specialty Board
      Way #443, Bldg. 18, Block 244, Plot 404,
      North Azaiba, Muscat,
      Sultanate of Oman

      Manuscript Queries
      Rabha Al-Abdulsalaam - 2418 1151
      Charie Ricafort - 2418 1082
      General Queries
      Jenny Manoguid - 2418 1050
    • FAQ
      Frequently asked questions